Intended for healthcare professionals

Rapid response to:

Practice Practice Pointer

Managing dyslipidaemia for the primary prevention of cardiovascular disease

BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k946 (Published 23 March 2018) Cite this as: BMJ 2018;360:k946

Rapid Response:

Re: Managing dyslipidaemia for the primary prevention of cardiovascular disease

Median survival of patients on long term pharmacologic therapies for dyslipidaemia was prolonged for only 3 days! [2]
Furthermore, statins for primary prevention in older people do not cut mortality or CHD events! [1]
References
[1] http://www.bmj.com/content/357/bmj.j2486
[2] bmjopen.bmj.com/content/5/9/e007118

Competing interests: No competing interests

23 March 2018
Stavros Saripanidis
Consultant in Obstetrics and Gynaecology
Thessaloniki, Hellas